7Baggers
 Regenxbio at Stifel 2025: Advancing Gene Therapy Innovations  Investing.com Tue, 11 Nov 2025 21:02:37 GMT
 regenxbio at guggenheim conference: strategic milestones ahead by investing.com  Investing.com Nigeria Tue, 11 Nov 2025 02:34:49 GMT
 Regenxbio at Guggenheim Conference: Strategic Milestones Ahead  Investing.com Mon, 10 Nov 2025 15:14:26 GMT
 barclays sticks to their buy rating for regenxbio (rgnx)  The Globe and Mail Sat, 08 Nov 2025 15:02:30 GMT
 regenxbio (rgnx) gets a buy from bank of america securities  The Globe and Mail Sat, 08 Nov 2025 14:48:01 GMT
 How Regenxbio Inc. (RGNX) Affects Rotational Strategy Timing  news.stocktradersdaily.com Sat, 08 Nov 2025 12:52:02 GMT
 regenxbio inc. earnings call: positive progress amid challenges  TipRanks Sat, 08 Nov 2025 00:21:50 GMT
 rgnx: rbc capital raises price target to $19, maintains outperfo  GuruFocus Fri, 07 Nov 2025 20:11:14 GMT
 Regenxbio’s Revenue Rises As Wall Street Remains Upbeat  Finimize Fri, 07 Nov 2025 17:11:14 GMT
 REGENXBIO Inc. (NASDAQ:RGNX) Q3 2025 Earnings Call Transcript  Insider Monkey Fri, 07 Nov 2025 13:35:12 GMT
 regenxbio: q3 earnings snapshot  theheraldreview.com Fri, 07 Nov 2025 11:56:43 GMT
 RegenXBio Inc. Earnings Call: Positive Progress Amid Challenges  TipRanks Fri, 07 Nov 2025 08:00:00 GMT
 REGENXBIO Reports Q3 2025 Financial and Operational Progress  TipRanks Fri, 07 Nov 2025 04:49:29 GMT
 regenxbio (rgnx) reports q3 loss, beats revenue estimates  sharewise.com Fri, 07 Nov 2025 04:34:40 GMT
 regenxbio q3 2025 earnings preview  MSN Fri, 07 Nov 2025 00:03:29 GMT
 regenxbio’s revenue rises as wall street remains upbeat  Finimize Thu, 06 Nov 2025 17:36:51 GMT
 regenxbio inc (rgnx) q3 2025 earnings: eps loss of $1.20 beats e  GuruFocus Thu, 06 Nov 2025 14:02:31 GMT
 Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates  Nasdaq Thu, 06 Nov 2025 13:25:00 GMT
 Regenxbio reports Q3 EPS ($1.20), consensus ($1.30)  TipRanks Thu, 06 Nov 2025 13:01:39 GMT
 Regenxbio (RGNX) Projects Financial Stability into 2027  GuruFocus Thu, 06 Nov 2025 12:50:13 GMT
 REGENXBIO (RGNX) Exceeds Q3 Revenue Expectations with Strong Gen  GuruFocus Thu, 06 Nov 2025 12:50:13 GMT
 REGENXBIO Inc. SEC 10-Q Report  TradingView Thu, 06 Nov 2025 12:33:00 GMT
 Regenxbio: Q3 Earnings Snapshot  CT Insider Thu, 06 Nov 2025 08:00:00 GMT
 REGENXBIO Inc. (RGNX) Q3 FY2025 earnings call transcript  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Rockville biotech company reports Q3 loss  Maryland Daily Record Thu, 06 Nov 2025 08:00:00 GMT
 regenxbio q3 2025 earnings preview  MSN Wed, 05 Nov 2025 15:24:43 GMT
 regenxbio advances gene therapies for diabetic retinopathy  Traders Union Tue, 04 Nov 2025 20:15:15 GMT
 stifel maintains regenxbio(rgnx.us) with buy rating  富途牛牛 Mon, 03 Nov 2025 16:31:00 GMT

REGENXBIO Inc
(NASDAQ:RGNX) 

RGNX stock logo

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates ...

Founded: 2008
Full Time Employees: 257
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends